US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALX Oncology Holdings

2.60

+0.280012.07%

Volume:3.30M

Turnover:8.49M

Market Cap:341.11M

PE:-1.29

High:2.66

Open:2.33

Low:2.20

Close:2.32

52wk High:2.66

52wk Low:0.4040

Shares:131.20M

Float Shares:105.00M

Volume Ratio:6.13

T/O Rate:3.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0149

EPS(LYR):-2.5846

ROE:-118.95%

ROA:-50.49%

PB:7.61

PE(LYR):-1.01

Loading ...

Overview Company News Filings

ALX Oncology Leadership to Present at TD Cowen 46th Annual Health Care Conference

Press Release: ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026

Director and 10% Owner Corey S. Goodman Reports Acquisition of ALX Oncology Holdings Inc. Common Shares

BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology

BUZZ-ALX Oncology rises as early breast cancer trial shows promise

ALX Oncology Announces $150 Million Offering of Common Stock and Pre-Funded Warrants

ALX Oncology Holdings Inc - Gross Proceeds Expected to Be $150 Mln

THOMSON REUTERS

ALX Oncology Announces Pricing of Underwritten Offering

THOMSON REUTERS

ALX Oncology Holdings Inc - Proceeds to Fund Evorpacept and Alx2004 Development

THOMSON REUTERS

ALX Oncology Reports CD47 Biomarker Predicts Response to Evorpacept in Advanced HER2-Positive Breast Cancer

New Data Demonstrate Cd47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination With Ziihera (Zanidatamab-Hrii) in Advanced Her2-Positive Breast Cancer

THOMSON REUTERS

ALX Oncology Holdings Inc - Cd47 Expression Predictive of Evorpacept Activity in Her2-Positive Mbc

THOMSON REUTERS

ALX Oncology Expands Inducement Equity Plan With Additional 1.3 Million Shares

ALX Oncology to Present at J.P. Morgan Healthcare Conference

ALX Oncology first patient dosed in Phase 2 ASPEN-09-Breast trial

ALX Oncology Holdings: Third Dose Cohort Initiated in Phase 1 Trial of Alx 2004

THOMSON REUTERS

ALX Oncology Advances Separate Clinical Trials Evaluating Investigational Cd47-Inhibitor Evorpacept and Novel Egfr-Targeted Antibody-Drug Conjugate Alx2004

THOMSON REUTERS

ALX Oncology Doses First Patient in Phase 2 Trial of Evorpacept for HER2-Positive Metastatic Breast Cancer

ALX Oncology Reports 92% Complete Response Rate with Evorpacept Combo in Frontline Indolent B-Cell Lymphoma Trial

ALX Oncology Announces Positive Results From Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination With Standard-of-Care Treatment in Patients With Indolent B-Cell Non-Hodgkin Lymphoma, at Ash Annual Meeting

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALXO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALXO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALXO\",,,,,undefined,":{"symbol":"ALXO","market":"US","secType":"STK","nameCN":"ALX Oncology Holdings","latestPrice":2.6,"timestamp":1771534800000,"preClose":2.32,"halted":0,"volume":3296744,"delay":0,"changeRate":0.12068965517241391,"floatShares":105000000,"shares":131197113,"eps":-2.014895,"marketStatus":"Pre-Mkt","change":0.28,"latestTime":"02-20 04:16:06 EST","open":2.33,"high":2.66,"low":2.2,"amount":8486567.416888,"amplitude":0.198276,"askPrice":2.89,"askSize":100,"bidPrice":2.29,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.014895,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771597800000},"marketStatusCode":1,"adr":0,"listingDate":1594958400000,"exchange":"NASDAQ","adjPreClose":2.6,"postHourTrading":{"tag":"盘后","latestPrice":2.56,"preClose":2.6,"latestTime":"19:51 EST","volume":3079,"amount":7973.4781,"timestamp":1771548715097,"change":-0.04,"changeRate":-0.015385,"amplitude":0.069885},"volumeRatio":6.125697856231595,"impliedVol":1.6644,"impliedVolPercentile":0.508},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALXO\",,,,,undefined,":{"symbol":"ALXO","floatShares":105000000,"roa":"-50.49%","roe":"-118.95%","lyrEps":-2.584575,"volumeRatio":6.125697856231595,"shares":131197113,"dividePrice":0,"high":2.66,"amplitude":0.198276,"preClose":2.32,"low":2.2,"week52Low":0.404,"pbRate":"7.61","week52High":2.66,"institutionHeld":0,"latestPrice":2.6,"eps":-2.014895,"divideRate":0,"volume":3296744,"delay":0,"ttmEps":-2.014895,"open":2.33,"prevYearClose":1.13,"prevWeekClose":2.21,"prevMonthClose":1.74,"prevQuarterClose":1.13,"fiveDayClose":2.48,"twentyDayClose":1.47,"sixtyDayClose":1.36,"earningDate":1772121600000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALXO\",params:#limit:5,,,undefined,":[{"date":"2026-02-27","symbol":"ALXO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772182800000,"name":null,"time":"Pre-Market","dateTimestamp":1772168400000,"actualEps":null},{"market":"US","date":"2025-11-07","symbol":"ALXO","fiscalQuarterEnding":"2025/09","expectedEps":-0.37,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-0.41},{"market":"US","date":"2025-08-12","symbol":"ALXO","fiscalQuarterEnding":"2025/06","expectedEps":-0.46,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-05-08","symbol":"ALXO","fiscalQuarterEnding":"2025/03","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2025-03-06","symbol":"ALXO","fiscalQuarterEnding":"2024/12","expectedEps":-0.68,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.55}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALXO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALXO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1762750800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALXO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALXO","date":"2026-02-18","current":-1.29039,"percent":0.526063,"low":-100.592217,"twenty":-8.842474,"median":-3.015559,"eighty":-0.605019,"high":-0.166798,"avg":-10.379762,"sd":18.538482,"marketCap":297817446},"quantilePoints":[{"date":"2021-02-26","current":-92.113927,"twenty":-93.460816,"median":-75.475824,"eighty":-53.300465,"marketCap":3199116671},{"date":"2021-03-05","current":-78.725341,"twenty":-93.759105,"median":-76.81098,"eighty":-53.358023,"marketCap":2734131099},{"date":"2021-03-12","current":-88.511514,"twenty":-93.531946,"median":-77.381667,"eighty":-53.551905,"marketCap":3074004872},{"date":"2021-03-19","current":-55.330616,"twenty":-93.460816,"median":-77.595675,"eighty":-53.798417,"marketCap":2530822377},{"date":"2021-03-26","current":-57.725615,"twenty":-93.382802,"median":-77.149826,"eighty":-53.896889,"marketCap":2640369628},{"date":"2021-04-01","current":-65.077297,"twenty":-93.180883,"median":-76.418632,"eighty":-53.947809,"marketCap":2976635547},{"date":"2021-04-09","current":-55.944718,"twenty":-92.985848,"median":-74.108199,"eighty":-54.058325,"marketCap":2558911416},{"date":"2021-04-16","current":-53.27776,"twenty":-92.939958,"median":-72.516197,"eighty":-53.495636,"marketCap":2436924734},{"date":"2021-04-23","current":-55.155158,"twenty":-92.917012,"median":-68.342322,"eighty":-53.294676,"marketCap":2522796938},{"date":"2021-04-30","current":-55.111578,"twenty":-92.882594,"median":-65.454531,"eighty":-53.32362,"marketCap":2520803591},{"date":"2021-05-07","current":-57.152096,"twenty":-92.848176,"median":-65.014338,"eighty":-53.495636,"marketCap":2614136887},{"date":"2021-05-14","current":-48.726164,"twenty":-92.721977,"median":-63.919275,"eighty":-53.294676,"marketCap":2228734742},{"date":"2021-05-21","current":-40.258673,"twenty":-92.653141,"median":-63.17505,"eighty":-52.94439,"marketCap":2192930159},{"date":"2021-05-28","current":-41.772712,"twenty":-92.263071,"median":-61.62783,"eighty":-52.571219,"marketCap":2275401390},{"date":"2021-06-04","current":-40.517167,"twenty":-92.143756,"median":-60.822445,"eighty":-52.379042,"marketCap":2207010613},{"date":"2021-06-11","current":-44.062235,"twenty":-91.957899,"median":-60.25961,"eighty":-52.086732,"marketCap":2400113984},{"date":"2021-06-18","current":-43.788969,"twenty":-91.78122,"median":-59.283293,"eighty":-50.873988,"marketCap":2385228933},{"date":"2021-06-25","current":-42.27493,"twenty":-91.480296,"median":-59.109127,"eighty":-50.078046,"marketCap":2302757701},{"date":"2021-07-02","current":-41.285265,"twenty":-91.377297,"median":-58.667015,"eighty":-49.378663,"marketCap":2248849677},{"date":"2021-07-09","current":-41.706242,"twenty":-91.34067,"median":-58.164259,"eighty":-48.538615,"marketCap":2271780702},{"date":"2021-07-16","current":-40.251287,"twenty":-91.104251,"median":-57.987212,"eighty":-47.965726,"marketCap":2192527860},{"date":"2021-07-23","current":-44.305958,"twenty":-90.936013,"median":-57.742597,"eighty":-46.338892,"marketCap":2413389841},{"date":"2021-07-30","current":-43.249823,"twenty":-90.466454,"median":-57.394267,"eighty":-44.85692,"marketCap":2355861128},{"date":"2021-08-06","current":-49.113956,"twenty":-89.509635,"median":-57.10274,"eighty":-45.119846,"marketCap":2675286288},{"date":"2021-08-13","current":-45.262916,"twenty":-88.805214,"median":-56.707355,"eighty":-45.130443,"marketCap":2689250914},{"date":"2021-08-20","current":-42.492549,"twenty":-88.557404,"median":-55.947352,"eighty":-44.982206,"marketCap":2524652298},{"date":"2021-08-27","current":-50.973404,"twenty":-88.256821,"median":-55.900461,"eighty":-45.082566,"marketCap":3028533845},{"date":"2021-09-03","current":-48.868468,"twenty":-88.066375,"median":-55.679405,"eighty":-45.130443,"marketCap":2903471172},{"date":"2021-09-10","current":-52.759205,"twenty":-88.038841,"median":-55.330616,"eighty":-45.198345,"marketCap":3134635404},{"date":"2021-09-17","current":-52.833896,"twenty":-87.975981,"median":-55.194935,"eighty":-45.273044,"marketCap":3139073112},{"date":"2021-09-24","current":-50.912293,"twenty":-87.775903,"median":-55.111578,"eighty":-45.344367,"marketCap":3024902994},{"date":"2021-10-01","current":-50.518467,"twenty":-87.47246,"median":-54.984083,"eighty":-45.527983,"marketCap":3001504171},{"date":"2021-10-08","current":-41.548723,"twenty":-87.079132,"median":-54.929153,"eighty":-45.344367,"marketCap":2468575809},{"date":"2021-10-15","current":-40.054897,"twenty":-86.164209,"median":-54.475312,"eighty":-45.077267,"marketCap":2379821654},{"date":"2021-10-22","current":-36.70058,"twenty":-84.954992,"median":-54.178901,"eighty":-44.359134,"marketCap":2180528231},{"date":"2021-10-29","current":-38.051813,"twenty":-84.221162,"median":-53.915984,"eighty":-43.969177,"marketCap":2260810399},{"date":"2021-11-05","current":-34.602434,"twenty":-83.375712,"median":-53.495636,"eighty":-43.582173,"marketCap":2055868986},{"date":"2021-11-12","current":-25.205542,"twenty":-82.343867,"median":-53.311679,"eighty":-43.170059,"marketCap":1860143780},{"date":"2021-11-19","current":-21.001874,"twenty":-81.732906,"median":-53.27776,"eighty":-42.526625,"marketCap":1549917319},{"date":"2021-11-26","current":-18.433576,"twenty":-80.942444,"median":-53.091921,"eighty":-42.023386,"marketCap":1360379481},{"date":"2021-12-03","current":-16.106742,"twenty":-80.524899,"median":-52.985295,"eighty":-41.694425,"marketCap":1188661440},{"date":"2021-12-10","current":-17.056134,"twenty":-80.373956,"median":-52.932947,"eighty":-41.567457,"marketCap":1258725641},{"date":"2021-12-17","current":-13.110394,"twenty":-80.254576,"median":-52.792486,"eighty":-41.255723,"marketCap":967533962},{"date":"2021-12-23","current":-12.764661,"twenty":-79.838188,"median":-52.604712,"eighty":-40.856903,"marketCap":942019253},{"date":"2021-12-31","current":-11.793318,"twenty":-79.289904,"median":-52.535131,"eighty":-40.627951,"marketCap":870335071},{"date":"2022-01-07","current":-10.53112,"twenty":-79.001733,"median":-52.37212,"eighty":-40.450697,"marketCap":777186134},{"date":"2022-01-14","current":-10.152461,"twenty":-78.808386,"median":-52.330066,"eighty":-40.369456,"marketCap":749241453},{"date":"2022-01-21","current":-8.473189,"twenty":-78.74195,"median":-52.195625,"eighty":-40.147016,"marketCap":625312866},{"date":"2022-01-28","current":-8.341481,"twenty":-78.655834,"median":-51.618626,"eighty":-39.843604,"marketCap":615592977},{"date":"2022-02-04","current":-7.507333,"twenty":-78.517591,"median":-51.204689,"eighty":-39.21928,"marketCap":554033679},{"date":"2022-02-11","current":-8.231725,"twenty":-78.430306,"median":-50.897527,"eighty":-38.45245,"marketCap":607493070},{"date":"2022-02-18","current":-8.231725,"twenty":-78.401772,"median":-50.803651,"eighty":-37.275023,"marketCap":607493070},{"date":"2022-02-25","current":-9.246971,"twenty":-78.298748,"median":-50.561615,"eighty":-36.737247,"marketCap":682417215},{"date":"2022-03-04","current":-8.095702,"twenty":-78.117892,"median":-50.477726,"eighty":-35.075026,"marketCap":675691617},{"date":"2022-03-11","current":-8.825922,"twenty":-77.950932,"median":-50.246862,"eighty":-26.858361,"marketCap":736637945},{"date":"2022-03-18","current":-9.736263,"twenty":-77.842025,"median":-50.16538,"eighty":-24.334226,"marketCap":812617700},{"date":"2022-03-25","current":-8.738296,"twenty":-77.552873,"median":-50.084428,"eighty":-20.659434,"marketCap":729324385},{"date":"2022-04-01","current":-8.850263,"twenty":-77.349566,"median":-49.785034,"eighty":-18.326015,"marketCap":738669489},{"date":"2022-04-08","current":-8.241746,"twenty":-77.221162,"median":-49.531736,"eighty":-17.51711,"marketCap":687880883},{"date":"2022-04-14","current":-7.793878,"twenty":-76.878749,"median":-49.323406,"eighty":-16.89589,"marketCap":650500468},{"date":"2022-04-22","current":-7.018746,"twenty":-76.450733,"median":-49.062508,"eighty":-13.33759,"marketCap":585805636},{"date":"2022-04-29","current":-6.229137,"twenty":-76.041509,"median":-48.76637,"eighty":-12.649417,"marketCap":519902502},{"date":"2022-05-06","current":-5.12271,"twenty":-75.292049,"median":-48.533182,"eighty":-12.244416,"marketCap":427556752},{"date":"2022-05-13","current":-4.189039,"twenty":-74.289836,"median":-48.498423,"eighty":-12.034782,"marketCap":392977948},{"date":"2022-05-20","current":-3.794419,"twenty":-73.182011,"median":-48.249313,"eighty":-11.086487,"marketCap":355958286},{"date":"2022-05-27","current":-3.490866,"twenty":-72.899487,"median":-48.0929,"eighty":-10.458681,"marketCap":327481623},{"date":"2022-06-03","current":-3.295724,"twenty":-72.026844,"median":-47.774966,"eighty":-9.81182,"marketCap":309175197},{"date":"2022-06-10","current":-2.942301,"twenty":-69.838643,"median":-47.421347,"eighty":-9.247467,"marketCap":276020225},{"date":"2022-06-17","current":-2.805702,"twenty":-68.686227,"median":-46.559829,"eighty":-9.18227,"marketCap":263205727},{"date":"2022-06-24","current":-3.469184,"twenty":-67.769149,"median":-46.395038,"eighty":-9.098538,"marketCap":325447576},{"date":"2022-07-01","current":-3.568923,"twenty":-65.99845,"median":-45.687745,"eighty":-8.994531,"marketCap":334804193},{"date":"2022-07-08","current":-4.228067,"twenty":-65.563315,"median":-45.3584,"eighty":-8.846368,"marketCap":396639233},{"date":"2022-07-15","current":-4.492593,"twenty":-65.297717,"median":-45.155297,"eighty":-8.814531,"marketCap":421454610},{"date":"2022-07-22","current":-5.051999,"twenty":-65.11354,"median":-44.961089,"eighty":-8.736349,"marketCap":473933032},{"date":"2022-07-29","current":-4.197712,"twenty":-64.976563,"median":-44.438898,"eighty":-8.619165,"marketCap":393791566},{"date":"2022-08-05","current":-4.973942,"twenty":-64.743307,"median":-44.265338,"eighty":-8.538703,"marketCap":466610462},{"date":"2022-08-12","current":-5.356359,"twenty":-64.073678,"median":-43.907138,"eighty":-8.41026,"marketCap":591647383},{"date":"2022-08-19","current":-5.112888,"twenty":-63.886724,"median":-43.707728,"eighty":-8.340383,"marketCap":564754320},{"date":"2022-08-26","current":-4.887862,"twenty":-63.433892,"median":-43.456619,"eighty":-8.230808,"marketCap":539898611},{"date":"2022-09-02","current":-4.921063,"twenty":-63.086449,"median":-43.183353,"eighty":-8.158015,"marketCap":543565847},{"date":"2022-09-09","current":-4.82515,"twenty":-62.661917,"median":-42.84731,"eighty":-7.986968,"marketCap":532971610},{"date":"2022-09-16","current":-4.493144,"twenty":-61.944008,"median":-42.492549,"eighty":-7.729088,"marketCap":496299251},{"date":"2022-09-23","current":-3.611485,"twenty":-61.460423,"median":-42.033813,"eighty":-7.54782,"marketCap":398913766},{"date":"2022-09-30","current":-3.530328,"twenty":-61.032994,"median":-41.772712,"eighty":-7.202887,"marketCap":389949412},{"date":"2022-10-07","current":-3.692642,"twenty":-60.743489,"median":-41.658236,"eighty":-6.707777,"marketCap":407878120},{"date":"2022-10-14","current":-4.054159,"twenty":-60.626043,"median":-41.588073,"eighty":-6.066342,"marketCap":447810244},{"date":"2022-10-21","current":-4.319764,"twenty":-60.194965,"median":-41.442844,"eighty":-5.374091,"marketCap":477148131},{"date":"2022-10-28","current":-4.61488,"twenty":-59.641614,"median":-41.248337,"eighty":-5.193368,"marketCap":509745783},{"date":"2022-11-04","current":-4.504211,"twenty":-59.348016,"median":-40.938144,"eighty":-5.122179,"marketCap":497521663},{"date":"2022-11-11","current":-4.300453,"twenty":-59.217202,"median":-40.687035,"eighty":-5.030256,"marketCap":521262231},{"date":"2022-11-18","current":-3.537198,"twenty":-59.166887,"median":-40.572559,"eighty":-4.96312,"marketCap":428747355},{"date":"2022-11-25","current":-3.590996,"twenty":-59.119845,"median":-40.463886,"eighty":-4.89524,"marketCap":435268227},{"date":"2022-12-02","current":-3.816274,"twenty":-58.926924,"median":-40.435144,"eighty":-4.797114,"marketCap":462574380},{"date":"2022-12-09","current":-3.614533,"twenty":-58.707207,"median":-40.376841,"eighty":-4.756536,"marketCap":438121109},{"date":"2022-12-16","current":-3.506937,"twenty":-58.527063,"median":-40.251287,"eighty":-4.709417,"marketCap":425079364},{"date":"2022-12-23","current":-3.745664,"twenty":-58.255985,"median":-40.054897,"eighty":-4.634062,"marketCap":454015735},{"date":"2022-12-30","current":-3.789375,"twenty":-58.159166,"median":-39.906151,"eighty":-4.595265,"marketCap":459313944},{"date":"2023-01-06","current":-3.68178,"twenty":-58.138796,"median":-39.727822,"eighty":-4.504211,"marketCap":446272199},{"date":"2023-01-13","current":-3.365718,"twenty":-58.085303,"median":-39.240083,"eighty":-4.478389,"marketCap":407962074},{"date":"2023-01-20","current":-3.036207,"twenty":-57.928357,"median":-39.017899,"eighty":-4.414536,"marketCap":368021731},{"date":"2023-01-27","current":-3.086643,"twenty":-57.857645,"median":-38.302211,"eighty":-4.350751,"marketCap":374135049},{"date":"2023-02-03","current":-2.931974,"twenty":-57.764033,"median":-37.31848,"eighty":-4.296199,"marketCap":355387541},{"date":"2023-02-10","current":-2.747045,"twenty":-57.729011,"median":-37.155517,"eighty":-4.239666,"marketCap":332972042},{"date":"2023-02-17","current":-2.56884,"twenty":-57.621305,"median":-36.70058,"eighty":-4.223535,"marketCap":311371653},{"date":"2023-02-24","current":-2.205705,"twenty":-57.354074,"median":-35.54626,"eighty":-4.200241,"marketCap":267355765},{"date":"2023-03-03","current":-2.192256,"twenty":-57.16858,"median":-33.651476,"eighty":-4.170666,"marketCap":265725547},{"date":"2023-03-10","current":-1.783676,"twenty":-57.122482,"median":-27.791947,"eighty":-4.074467,"marketCap":220251834},{"date":"2023-03-17","current":-1.578503,"twenty":-57.05258,"median":-25.006111,"eighty":-4.025988,"marketCap":194916743},{"date":"2023-03-24","current":-1.542102,"twenty":-56.989742,"median":-23.916278,"eighty":-3.955655,"marketCap":190421808},{"date":"2023-03-31","current":-1.495773,"twenty":-56.654797,"median":-21.770169,"eighty":-3.901832,"marketCap":184700981},{"date":"2023-04-06","current":-1.449443,"twenty":-56.409431,"median":-20.145775,"eighty":-3.885205,"marketCap":178980154},{"date":"2023-04-14","current":-1.638069,"twenty":-56.204581,"median":-19.081139,"eighty":-3.85326,"marketCap":202272092},{"date":"2023-04-21","current":-1.654616,"twenty":-55.946825,"median":-18.126258,"eighty":-3.798897,"marketCap":204315245},{"date":"2023-04-28","current":-1.846551,"twenty":-55.942565,"median":-17.484184,"eighty":-3.767184,"marketCap":228015813},{"date":"2023-05-05","current":-2.101362,"twenty":-55.920558,"median":-17.017719,"eighty":-3.734905,"marketCap":259480361},{"date":"2023-05-12","current":-1.984089,"twenty":-55.832135,"median":-16.422292,"eighty":-3.693832,"marketCap":256211317},{"date":"2023-05-19","current":-1.902097,"twenty":-55.690123,"median":-13.17076,"eighty":-3.654578,"marketCap":245623501},{"date":"2023-05-26","current":-2.060341,"twenty":-55.614879,"median":-12.846979,"eighty":-3.612095,"marketCap":266058068},{"date":"2023-06-01","current":-2.11098,"twenty":-55.421299,"median":-12.572588,"eighty":-3.599066,"marketCap":272597130},{"date":"2023-06-09","current":-2.51292,"twenty":-55.335847,"median":-12.314661,"eighty":-3.56863,"marketCap":324500931},{"date":"2023-06-16","current":-3.025632,"twenty":-55.275002,"median":-12.21588,"eighty":-3.5537,"marketCap":390708930},{"date":"2023-06-23","current":-2.281884,"twenty":-55.245267,"median":-12.034782,"eighty":-3.543223,"marketCap":294666463},{"date":"2023-06-30","current":-2.319862,"twenty":-55.202891,"median":-11.793318,"eighty":-3.523749,"marketCap":299570759},{"date":"2023-07-07","current":-2.003373,"twenty":-55.149894,"median":-11.261,"eighty":-3.507192,"marketCap":258701624},{"date":"2023-07-14","current":-2.250235,"twenty":-55.125388,"median":-10.786303,"eighty":-3.491733,"marketCap":290579549},{"date":"2023-07-21","current":-2.155288,"twenty":-55.099265,"median":-10.410388,"eighty":-3.446634,"marketCap":278318809},{"date":"2023-07-28","current":-1.803986,"twenty":-55.039457,"median":-9.925154,"eighty":-3.375531,"marketCap":232954069},{"date":"2023-08-04","current":-1.788161,"twenty":-54.991977,"median":-9.278658,"eighty":-3.333018,"marketCap":230910612},{"date":"2023-08-11","current":-1.590872,"twenty":-54.964509,"median":-9.227764,"eighty":-3.228425,"marketCap":207405167},{"date":"2023-08-18","current":-1.43936,"twenty":-54.936896,"median":-9.186164,"eighty":-3.186841,"marketCap":187652294},{"date":"2023-08-25","current":-1.417265,"twenty":-54.918358,"median":-9.156556,"eighty":-3.13237,"marketCap":184771667},{"date":"2023-09-01","current":-1.344666,"twenty":-54.835061,"median":-9.069329,"eighty":-3.106144,"marketCap":175306748},{"date":"2023-09-08","current":-1.568777,"twenty":-54.674603,"median":-9.025516,"eighty":-3.086643,"marketCap":204524540},{"date":"2023-09-15","current":-1.581403,"twenty":-54.276021,"median":-8.934523,"eighty":-3.025632,"marketCap":206170613},{"date":"2023-09-22","current":-1.584559,"twenty":-54.256262,"median":-8.83079,"eighty":-2.959169,"marketCap":206582131},{"date":"2023-09-29","current":-1.562464,"twenty":-54.178901,"median":-8.819987,"eighty":-2.922787,"marketCap":203701504},{"date":"2023-10-06","current":-2.439673,"twenty":-54.058325,"median":-8.780507,"eighty":-2.805702,"marketCap":318065046},{"date":"2023-10-13","current":-3.610879,"twenty":-53.947809,"median":-8.733428,"eighty":-2.875086,"marketCap":470757533},{"date":"2023-10-20","current":-2.69383,"twenty":-53.884159,"median":-8.640933,"eighty":-2.875086,"marketCap":351200064},{"date":"2023-10-27","current":-2.644157,"twenty":-53.841288,"median":-8.62136,"eighty":-2.8031,"marketCap":344724035},{"date":"2023-11-03","current":-2.942198,"twenty":-53.664443,"median":-8.578747,"eighty":-2.767568,"marketCap":383580212},{"date":"2023-11-10","current":-2.995692,"twenty":-53.494397,"median":-8.480285,"eighty":-2.780558,"marketCap":390554398},{"date":"2023-11-17","current":-3.046261,"twenty":-53.424971,"median":-8.422523,"eighty":-2.799034,"marketCap":444881991},{"date":"2023-11-24","current":-3.015559,"twenty":-53.318844,"median":-8.370743,"eighty":-2.802233,"marketCap":440398298},{"date":"2023-12-01","current":-2.674433,"twenty":-53.298726,"median":-8.341481,"eighty":-2.802233,"marketCap":390579486},{"date":"2023-12-08","current":-3.155421,"twenty":-53.291293,"median":-8.236735,"eighty":-2.798257,"marketCap":460824011},{"date":"2023-12-15","current":-4.49946,"twenty":-53.270425,"median":-8.227142,"eighty":-2.802233,"marketCap":657110130},{"date":"2023-12-22","current":-4.44488,"twenty":-53.211253,"median":-8.17522,"eighty":-2.810832,"marketCap":649139120},{"date":"2023-12-29","current":-5.21412,"twenty":-53.121754,"median":-8.095702,"eighty":-2.826221,"marketCap":761480541},{"date":"2024-01-05","current":-4.455113,"twenty":-53.072909,"median":-8.065863,"eighty":-2.834762,"marketCap":650633684},{"date":"2024-01-12","current":-4.792829,"twenty":-53.028094,"median":-7.880505,"eighty":-2.853962,"marketCap":699954308},{"date":"2024-01-19","current":-4.352776,"twenty":-52.996307,"median":-7.737821,"eighty":-2.875208,"marketCap":635688041},{"date":"2024-01-26","current":-4.939513,"twenty":-52.96243,"median":-7.643702,"eighty":-2.875697,"marketCap":721376397},{"date":"2024-02-02","current":-5.116899,"twenty":-52.942101,"median":-7.507333,"eighty":-2.879044,"marketCap":747282180},{"date":"2024-02-09","current":-4.71437,"twenty":-52.913137,"median":-7.309163,"eighty":-2.897551,"marketCap":688495981},{"date":"2024-02-16","current":-5.727516,"twenty":-52.83227,"median":-7.018746,"eighty":-2.918978,"marketCap":836457853},{"date":"2024-02-23","current":-5.475082,"twenty":-52.825768,"median":-6.740921,"eighty":-2.922787,"marketCap":799591932},{"date":"2024-03-01","current":-5.004327,"twenty":-52.759205,"median":-6.282752,"eighty":-2.931974,"marketCap":730841972},{"date":"2024-03-08","current":-5.031296,"twenty":-52.638205,"median":-5.931816,"eighty":-2.942198,"marketCap":809057506},{"date":"2024-03-15","current":-3.477477,"twenty":-52.571219,"median":-5.60471,"eighty":-2.942198,"marketCap":559195714},{"date":"2024-03-22","current":-3.901636,"twenty":-52.544424,"median":-5.543307,"eighty":-2.942301,"marketCap":627402545},{"date":"2024-03-28","current":-3.558566,"twenty":-52.53699,"median":-5.410268,"eighty":-2.944036,"marketCap":572235255},{"date":"2024-04-05","current":-3.505546,"twenty":-52.476531,"median":-5.405151,"eighty":-2.956229,"marketCap":563709401},{"date":"2024-04-12","current":-4.172973,"twenty":-52.399301,"median":-5.385913,"eighty":-2.97616,"marketCap":671034857},{"date":"2024-04-19","current":-4.909013,"twenty":-52.365198,"median":-5.336925,"eighty":-2.983672,"marketCap":789393770},{"date":"2024-04-26","current":-5.297814,"twenty":-52.346888,"median":-5.304714,"eighty":-2.990242,"marketCap":851915025},{"date":"2024-05-03","current":-5.219305,"twenty":-52.332746,"median":-5.310685,"eighty":-2.99489,"marketCap":839290321},{"date":"2024-05-10","current":-5.150088,"twenty":-52.226272,"median":-5.297814,"eighty":-2.995826,"marketCap":855954931},{"date":"2024-05-17","current":-4.595538,"twenty":-52.196565,"median":-5.232916,"eighty":-3.00889,"marketCap":763787568},{"date":"2024-05-24","current":-4.604942,"twenty":-51.815379,"median":-5.21412,"eighty":-3.012566,"marketCap":765350571},{"date":"2024-05-31","current":-3.332235,"twenty":-51.667547,"median":-5.190766,"eighty":-3.014404,"marketCap":553824137},{"date":"2024-06-07","current":-2.824406,"twenty":-51.615878,"median":-5.146845,"eighty":-2.994087,"marketCap":469421964},{"date":"2024-06-14","current":-2.523471,"twenty":-51.396921,"median":-5.133955,"eighty":-2.953289,"marketCap":419405861},{"date":"2024-06-21","current":-2.056393,"twenty":-51.236842,"median":-5.12271,"eighty":-2.942198,"marketCap":341776701},{"date":"2024-06-28","current":-1.890252,"twenty":-51.112175,"median":-5.115194,"eighty":-2.912637,"marketCap":314163645},{"date":"2024-07-05","current":-1.708437,"twenty":-50.961182,"median":-5.109776,"eighty":-2.875697,"marketCap":283945583},{"date":"2024-07-12","current":-2.213131,"twenty":-50.906387,"median":-5.081423,"eighty":-2.825795,"marketCap":367826755},{"date":"2024-07-19","current":-1.927869,"twenty":-50.873988,"median":-5.038774,"eighty":-2.798257,"marketCap":320415658},{"date":"2024-07-26","current":-1.896521,"twenty":-50.831847,"median":-5.031296,"eighty":-2.760148,"marketCap":315205647},{"date":"2024-08-02","current":-0.896537,"twenty":-50.794145,"median":-5.016014,"eighty":-2.734048,"marketCap":149006306},{"date":"2024-08-09","current":-0.793162,"twenty":-50.71722,"median":-5.014561,"eighty":-2.708922,"marketCap":135981279},{"date":"2024-08-16","current":-0.780359,"twenty":-50.558417,"median":-4.997808,"eighty":-2.674037,"marketCap":133786346},{"date":"2024-08-23","current":-0.734275,"twenty":-50.540195,"median":-4.963392,"eighty":-2.642976,"marketCap":125885578},{"date":"2024-08-30","current":-0.712769,"twenty":-50.502171,"median":-4.948317,"eighty":-2.612107,"marketCap":122198552},{"date":"2024-09-06","current":-0.586806,"twenty":-50.436985,"median":-4.937807,"eighty":-2.56884,"marketCap":100603118},{"date":"2024-09-13","current":-0.682046,"twenty":-50.301183,"median":-4.915634,"eighty":-2.53191,"marketCap":116931373},{"date":"2024-09-20","current":-0.635962,"twenty":-50.246862,"median":-4.910618,"eighty":-2.507797,"marketCap":109030605},{"date":"2024-09-27","current":-0.605239,"twenty":-50.185751,"median":-4.905401,"eighty":-2.404084,"marketCap":103763426},{"date":"2024-10-04","current":-0.516143,"twenty":-50.178961,"median":-4.889809,"eighty":-2.343562,"marketCap":88488607},{"date":"2024-10-11","current":-0.473131,"twenty":-50.1518,"median":-4.867583,"eighty":-2.319862,"marketCap":81114556},{"date":"2024-10-18","current":-0.454698,"twenty":-50.146298,"median":-4.856379,"eighty":-2.304038,"marketCap":77954249},{"date":"2024-10-25","current":-0.451625,"twenty":-50.084428,"median":-4.82515,"eighty":-2.246054,"marketCap":77427531},{"date":"2024-11-01","current":-0.445481,"twenty":-50.052516,"median":-4.797783,"eighty":-2.195618,"marketCap":76374095},{"date":"2024-11-08","current":-0.505941,"twenty":-49.812294,"median":-4.792829,"eighty":-2.17586,"marketCap":76477500},{"date":"2024-11-15","current":-0.450113,"twenty":-49.757774,"median":-4.779917,"eighty":-2.156705,"marketCap":68038604},{"date":"2024-11-22","current":-0.491984,"twenty":-49.67739,"median":-4.758749,"eighty":-2.148545,"marketCap":74367776},{"date":"2024-11-29","current":-0.516409,"twenty":-49.560867,"median":-4.75541,"eighty":-2.140096,"marketCap":78059793},{"date":"2024-12-06","current":-0.565258,"twenty":-49.365072,"median":-4.734631,"eighty":-2.113511,"marketCap":85443828},{"date":"2024-12-13","current":-0.505941,"twenty":-49.323406,"median":-4.71437,"eighty":-2.107947,"marketCap":76477500},{"date":"2024-12-20","current":-0.565258,"twenty":-49.285832,"median":-4.708903,"eighty":-2.095409,"marketCap":85443828},{"date":"2024-12-27","current":-0.565258,"twenty":-49.178949,"median":-4.684322,"eighty":-2.063954,"marketCap":85443828},{"date":"2025-01-03","current":-0.631554,"twenty":-49.072798,"median":-4.662836,"eighty":-2.056707,"marketCap":95465018},{"date":"2025-01-10","current":-0.617597,"twenty":-48.982542,"median":-4.635911,"eighty":-2.03169,"marketCap":93355294},{"date":"2025-01-17","current":-0.607129,"twenty":-48.848048,"median":-4.61488,"eighty":-2.005467,"marketCap":91773000},{"date":"2025-01-24","current":-0.528621,"twenty":-48.76637,"median":-4.605341,"eighty":-1.985539,"marketCap":79905802},{"date":"2025-01-31","current":-0.50943,"twenty":-48.726164,"median":-4.594142,"eighty":-1.94957,"marketCap":77004931},{"date":"2025-02-07","current":-0.380328,"twenty":-48.56541,"median":-4.557451,"eighty":-1.927869,"marketCap":57489983},{"date":"2025-02-14","current":-0.383817,"twenty":-48.500955,"median":-4.538639,"eighty":-1.902097,"marketCap":58017414},{"date":"2025-02-21","current":-0.390796,"twenty":-48.498929,"median":-4.511686,"eighty":-1.885007,"marketCap":59072276},{"date":"2025-02-28","current":-0.383817,"twenty":-48.498423,"median":-4.496929,"eighty":-1.861402,"marketCap":58017414},{"date":"2025-03-07","current":-0.419631,"twenty":-48.444833,"median":-4.49091,"eighty":-1.84135,"marketCap":56587193},{"date":"2025-03-14","current":-0.328618,"twenty":-48.303038,"median":-4.468755,"eighty":-1.815444,"marketCap":44314178},{"date":"2025-03-21","current":-0.279925,"twenty":-48.236339,"median":-4.454794,"eighty":-1.787264,"marketCap":37747928},{"date":"2025-03-28","current":-0.25934,"twenty":-48.213399,"median":-4.441499,"eighty":-1.751836,"marketCap":34971953},{"date":"2025-04-04","current":-0.204233,"twenty":-48.116285,"median":-4.391678,"eighty":-1.697673,"marketCap":27540880},{"date":"2025-04-11","current":-0.19398,"twenty":-48.023478,"median":-4.369832,"eighty":-1.649321,"marketCap":26158231},{"date":"2025-04-17","current":-0.217733,"twenty":-47.867428,"median":-4.352776,"eighty":-1.635773,"marketCap":29361279},{"date":"2025-04-25","current":-0.214494,"twenty":-47.765754,"median":-4.330512,"eighty":-1.611596,"marketCap":28924488},{"date":"2025-05-02","current":-0.211009,"twenty":-47.622334,"median":-4.300453,"eighty":-1.593193,"marketCap":28454605},{"date":"2025-05-09","current":-0.17358,"twenty":-47.399454,"median":-4.274354,"eighty":-1.588431,"marketCap":22569409},{"date":"2025-05-16","current":-0.179787,"twenty":-46.89039,"median":-4.262759,"eighty":-1.580553,"marketCap":23376414},{"date":"2025-05-23","current":-0.196845,"twenty":-46.579656,"median":-4.239269,"eighty":-1.56562,"marketCap":25594341},{"date":"2025-05-30","current":-0.192036,"twenty":-46.538101,"median":-4.230236,"eighty":-1.56057,"marketCap":24969046},{"date":"2025-06-06","current":-0.215793,"twenty":-46.46132,"median":-4.205406,"eighty":-1.543934,"marketCap":28058110},{"date":"2025-06-13","current":-0.222247,"twenty":-46.338892,"median":-4.199872,"eighty":-1.532926,"marketCap":28897181},{"date":"2025-06-20","current":-0.199969,"twenty":-46.143414,"median":-4.197818,"eighty":-1.525556,"marketCap":26000515},{"date":"2025-06-27","current":-0.186034,"twenty":-45.694123,"median":-4.182212,"eighty":-1.515747,"marketCap":24188763},{"date":"2025-07-03","current":-0.189117,"twenty":-45.677113,"median":-4.172973,"eighty":-1.504678,"marketCap":24589593},{"date":"2025-07-11","current":-0.204284,"twenty":-45.428563,"median":-4.119656,"eighty":-1.486708,"marketCap":26561677},{"date":"2025-07-18","current":-0.202229,"twenty":-45.278109,"median":-4.058986,"eighty":-1.437466,"marketCap":26294457},{"date":"2025-07-25","current":-0.221959,"twenty":-44.730224,"median":-4.009047,"eighty":-1.359817,"marketCap":28859770},{"date":"2025-08-01","current":-0.233262,"twenty":-44.181881,"median":-3.935599,"eighty":-0.885252,"marketCap":30329481},{"date":"2025-08-08","current":-0.289698,"twenty":-43.596945,"median":-3.894245,"eighty":-0.807811,"marketCap":37667345},{"date":"2025-08-15","current":-0.300893,"twenty":-43.069615,"median":-3.855616,"eighty":-0.789576,"marketCap":35075992},{"date":"2025-08-22","current":-0.47316,"twenty":-42.185434,"median":-3.815291,"eighty":-0.766227,"marketCap":55157668},{"date":"2025-08-29","current":-0.523692,"twenty":-41.700334,"median":-3.787807,"eighty":-0.709082,"marketCap":61048292},{"date":"2025-09-05","current":-0.496129,"twenty":-41.559587,"median":-3.749027,"eighty":-0.669757,"marketCap":57835224},{"date":"2025-09-12","current":-0.542067,"twenty":-41.230612,"median":-3.728853,"eighty":-0.657468,"marketCap":63190338},{"date":"2025-09-19","current":-0.500723,"twenty":-40.678172,"median":-3.675221,"eighty":-0.643284,"marketCap":58370736},{"date":"2025-09-26","current":-0.822288,"twenty":-40.457661,"median":-3.648102,"eighty":-0.634119,"marketCap":95856529},{"date":"2025-10-03","current":-0.877413,"twenty":-40.325143,"median":-3.613009,"eighty":-0.634119,"marketCap":102282665},{"date":"2025-10-10","current":-0.891194,"twenty":-40.016872,"median":-3.596039,"eighty":-0.634119,"marketCap":103889199},{"date":"2025-10-17","current":-0.757975,"twenty":-39.337202,"median":-3.564097,"eighty":-0.634119,"marketCap":88359371},{"date":"2025-10-24","current":-0.803912,"twenty":-38.352291,"median":-3.551554,"eighty":-0.634119,"marketCap":93714484},{"date":"2025-10-31","current":-0.712037,"twenty":-37.177245,"median":-3.527293,"eighty":-0.634119,"marketCap":83004257},{"date":"2025-11-07","current":-0.542067,"twenty":-35.483791,"median":-3.507996,"eighty":-0.631554,"marketCap":63190338},{"date":"2025-11-14","current":-0.604873,"twenty":-25.357005,"median":-3.496164,"eighty":-0.628704,"marketCap":65332383},{"date":"2025-11-21","current":-0.682682,"twenty":-21.923827,"median":-3.481131,"eighty":-0.628704,"marketCap":73736481},{"date":"2025-11-28","current":-0.687702,"twenty":-19.210651,"median":-3.466206,"eighty":-0.628704,"marketCap":74278661},{"date":"2025-12-05","current":-0.687702,"twenty":-17.51711,"median":-3.431376,"eighty":-0.625971,"marketCap":74278661},{"date":"2025-12-12","current":-0.762998,"twenty":-16.485401,"median":-3.378156,"eighty":-0.625971,"marketCap":82411361},{"date":"2025-12-19","current":-0.707781,"twenty":-12.863442,"median":-3.35207,"eighty":-0.625971,"marketCap":76447381},{"date":"2025-12-26","current":-0.682682,"twenty":-12.323441,"median":-3.329157,"eighty":-0.625971,"marketCap":73736481},{"date":"2026-01-02","current":-0.567228,"twenty":-12.077587,"median":-3.242195,"eighty":-0.620388,"marketCap":61266341},{"date":"2026-01-09","current":-0.622445,"twenty":-11.144658,"median":-3.204325,"eighty":-0.605995,"marketCap":67230321},{"date":"2026-01-16","current":-0.607386,"twenty":-10.307217,"median":-3.158018,"eighty":-0.605995,"marketCap":65603781},{"date":"2026-01-23","current":-0.737899,"twenty":-9.395494,"median":-3.124149,"eighty":-0.605019,"marketCap":79700461},{"date":"2026-01-30","current":-0.788096,"twenty":-9.189085,"median":-3.102018,"eighty":-0.605019,"marketCap":85122261},{"date":"2026-02-06","current":-1.034062,"twenty":-9.086854,"median":-3.064917,"eighty":-0.605019,"marketCap":111689082},{"date":"2026-02-13","current":-1.207243,"twenty":-8.937744,"median":-3.025713,"eighty":-0.605019,"marketCap":130394292},{"date":"2026-02-18","current":-2.757314,"twenty":-8.842474,"median":-3.015559,"eighty":-0.605019,"marketCap":297817446}],"updateTime":1771578966355},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALXO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612940003","title":"ALX Oncology Leadership to Present at TD Cowen 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2612940003","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612940003?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:33","pubTimestamp":1771508017,"startTime":"0","endTime":"0","summary":"ALX Oncology Leadership to Present at TD Cowen 46th Annual Health Care Conference               ALX Oncology Holdings Inc. will participate in the Wells Fargo Executive Biotech Summit (one-on-one meet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL1z2xYC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014005.SGD","SG9999014021.USD","IE00BKPKM429.USD","LU2095319765.USD","BK4588","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BGHQF748.EUR","NDAQ","BK4585","ALXO","LU0314104364.USD","SG9999014039.USD","SG9999014013.SGD","BK4112"],"gpt_icon":0},{"id":"2612400749","title":"Press Release: ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2612400749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612400749?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:30","pubTimestamp":1771507800,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Feb. 19, 2026  -- ALX Oncology Holdings Inc. , a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced plans to report its fourth quarter and full year 2025 financial results and a business update on Friday, February 27th, 2026 before market open. The company will host a teleconference in conjunction with its financial results press release.Fourth Quarter and Full Year 2025 Results Webcast Information. Date & Time: Friday, February 27, 2026 at 5:30am PT / 8:30am ET. Participant Listening Options by Phone: To access the conference call, please dial 1-877- 407-0755 or +1-201-389-0913 and ask to be joined into the ALX Oncology Fourth Quarter and Full Year 2025 Financial Results Conference Call.Another option for instant telephone access to the event is to use the Call me link below:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALX","03160","BK4604","TM","BK4555","BK4080","BK4585","ALXO","BK4231","BK4099","BK4588","BK4139"],"gpt_icon":0},{"id":"2609313137","title":"Director and 10% Owner Corey S. Goodman Reports Acquisition of ALX Oncology Holdings Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2609313137","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609313137?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:16","pubTimestamp":1770239797,"startTime":"0","endTime":"0","summary":"Corey S. Goodman, Director and 10% Owner, has reported an acquisition of common shares of ALX Oncology Holdings Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ALX Oncology Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL887nRt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner Corey S. Goodman Reports Acquisition of ALX Oncology Holdings Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2607049612","title":"BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2607049612","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607049612?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:12","pubTimestamp":1769782350,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX OncologyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: http","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nL6N3YV0MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","CDE","IE00BFXG1179.USD","LU0234572021.USD","IE00B2Q91V27.USD","NEM","KYIV","LU0170899867.USD","APD","LU0690374615.EUR","BK4581","DVN","HL","LU2242646821.SGD","LU0683600562.USD","LU0498741890.SGD","AXP","AU","VZ","IE000M9KFDE8.USD","LU0690374961.EUR","LU2347655156.SGD","APA","BK4146","CORT","PCVX","SG9999002521.SGD","RMD","ALXO","LU2404859667.USD","LU0266512473.USD","LU1150488135.SGD","ALV","SNDR","DECK","LU0070217475.USD","XOM","IE00BGHQF524.EUR","MENS","TNXP","CVX","IE00BWXC8680.SGD","LXRX","SYK","LU0345780521.USD","VEON","BK4232","LU2404859741.USD","BK4534"],"gpt_icon":1},{"id":"2607045002","title":"BUZZ-ALX Oncology rises as early breast cancer trial shows promise","url":"https://stock-news.laohu8.com/highlight/detail?id=2607045002","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607045002?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:40","pubTimestamp":1769780412,"startTime":"0","endTime":"0","summary":"BUZZ-ALX Oncology rises as early breast cancer trial shows promise** Shares of drug developer ALX Oncology ALXO.O rise 4.46% to $1.64 premarket** Co says experimental cancer drug, evorpacept, showed encouraging results in an early-stage trial for patients with advanced breast cancer** Co says 5 of 9 patients saw tumor shrinkage; treatment worked better in patients with higher CD47 levels, a protein that helps cancer evade the immune system** Co says median time before cancer worsened was 7.4 months** Shares down ~32% in 2025  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nL4N3YV1FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2607704543","title":"ALX Oncology Announces $150 Million Offering of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704543","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607704543?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779854,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings Inc. announced the pricing of an underwritten offering consisting of 76,979,112 shares of common stock and pre-funded warrants to purchase 18,574,120 shares of common stock. The shares are being sold at $1.57 per share, while the pre-funded warrants are priced at $1.569 per warrant. The offering is expected to raise approximately $150 million in gross proceeds before expenses. The proceeds will be used to fund the continued clinical development of evorpacept and the ALX2004 program, as well as for working capital and general corporate purposes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ALX Oncology Holdings Inc. published the original content used to generate this news brief via GlobeNewswire  on January 30, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDLbBcBpP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO","LU2095319765.USD","BK4585","LU0314104364.USD","IE00BKPKM429.USD","SG9999014005.SGD","BK4588","SG9999014013.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","NDAQ","BK4112","LU2210150020.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","BK4139","SG9999014039.USD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2607410045","title":"ALX Oncology Holdings Inc - Gross Proceeds Expected to Be $150 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2607410045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607410045?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779821,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA7NRNCC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2607191045","title":"ALX Oncology Announces Pricing of Underwritten Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2607191045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607191045?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779821,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA7NRNCC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2607045414","title":"ALX Oncology Holdings Inc - Proceeds to Fund Evorpacept and Alx2004 Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2607045414","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607045414?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779821,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA7NRNCC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2607043078","title":"ALX Oncology Reports CD47 Biomarker Predicts Response to Evorpacept in Advanced HER2-Positive Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2607043078","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607043078?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:15","pubTimestamp":1769778909,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings Inc. has announced new data from a Phase 1b/2 clinical trial evaluating its investigational CD47-inhibitor evorpacept in combination with Jazz Pharmaceuticals' zanidatamab-hrii  in heavily pretreated patients with metastatic HER2-positive breast cancer. The exploratory analysis indicates that CD47 expression is a predictive biomarker for response to evorpacept in combination with HER2-targeted agents. These findings are consistent with previous results from the ASPEN-06 trial in HER2-positive gastric cancer. The full data set from the biomarker analysis has been submitted for presentation at an upcoming scientific conference.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ALX Oncology Holdings Inc. published the o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL7YchK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE00BGHQF748.EUR","LU0109394709.USD","BK4585","LU0320765992.SGD","LU0823416689.USD","LU2095319765.USD","IE00BN0W2T93.GBP","BK4532","LU0314104364.USD","LU0154245756.USD","IE00BN0W2W23.USD","ALXO","BK4533","LU2210150020.SGD","SG9999014039.USD","BK4112","SG9999014021.USD","SG9999014013.SGD","SG9999014005.SGD","BK4007","IE00BKPKM429.USD","LU0154245673.USD","IE00BN0W2V16.EUR","NDAQ","LU2210149790.SGD","BK4588","BK4139","IE00B3QW5Z07.USD","JAZZ","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2607832045","title":"New Data Demonstrate Cd47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination With Ziihera (Zanidatamab-Hrii) in Advanced Her2-Positive Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2607832045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607832045?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:15","pubTimestamp":1769778900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA5C95JM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2607704583","title":"ALX Oncology Holdings Inc - Cd47 Expression Predictive of Evorpacept Activity in Her2-Positive Mbc","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704583","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607704583?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:15","pubTimestamp":1769778900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA5C95JM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2605443567","title":"ALX Oncology Expands Inducement Equity Plan With Additional 1.3 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605443567","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605443567?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:44","pubTimestamp":1769031845,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings Inc. has amended its 2025 Inducement Equity Incentive Plan, increasing the total number of shares reserved for issuance under the plan by 1,300,000, bringing the aggregate total to 2,800,000 shares. The plan allows for the grant of equity-based awards, such as nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, and performance shares, to individuals entering employment with the company who were not previously employees or non-employee directors. The terms of the Inducement Plan are substantially similar to the company’s Amended and Restated 2020 Equity Incentive Plan, including the treatment of equity awards in the event of a merger or change in control.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be inte","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL80mfNG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2602396878","title":"ALX Oncology to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2602396878","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602396878?lang=en_us&edition=fundamental","pubTime":"2026-01-09 00:00","pubTimestamp":1767888013,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Chief Executive Officer Jason Lettmann and Chief Medical Officer Barbara Klencke are scheduled to deliver a corporate presentation on Thursday, January 15, 2026, at 12:00 p.m. Pacific Time. A live webcast of the event will be available on the company's website, with a replay accessible for up to 90 days following the presentation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ALX Oncology Holdings Inc. published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL8tfFdM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014013.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014005.SGD","BK4588","IE00B64PRP62.GBP","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","ALXO","IE00BGHQF748.EUR","NDAQ","BK4139","IE00BKPKM429.USD","BK4585","BK4112"],"gpt_icon":0},{"id":"2601765367","title":"ALX Oncology first patient dosed in Phase 2 ASPEN-09-Breast trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601765367","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601765367?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:55","pubTimestamp":1767880550,"startTime":"0","endTime":"0","summary":"ALX Oncology (ALXO) announced that the first patient has been dosed in the Company’s Phase 2 ASPEN-09-Breast trial evaluating its investigational C...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alx-oncology-first-patient-dosed-in-phase-2-aspen-09-breast-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alx-oncology-first-patient-dosed-in-phase-2-aspen-09-breast-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","ALX","BK4139","ALXO","BK4231"],"gpt_icon":0},{"id":"2601636297","title":"ALX Oncology Holdings: Third Dose Cohort Initiated in Phase 1 Trial of Alx 2004","url":"https://stock-news.laohu8.com/highlight/detail?id=2601636297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601636297?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:32","pubTimestamp":1767879145,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y9111:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2601362908","title":"ALX Oncology Advances Separate Clinical Trials Evaluating Investigational Cd47-Inhibitor Evorpacept and Novel Egfr-Targeted Antibody-Drug Conjugate Alx2004","url":"https://stock-news.laohu8.com/highlight/detail?id=2601362908","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601362908?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:32","pubTimestamp":1767879145,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y9111:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2601621903","title":"ALX Oncology Doses First Patient in Phase 2 Trial of Evorpacept for HER2-Positive Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601621903","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601621903?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:30","pubTimestamp":1767879018,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings Inc. announced the initiation of the third dose cohort in its Phase 1 clinical trial of ALX2004, a novel EGFR-targeted antibody-drug conjugate, for participants with advanced or metastatic EGFR-expressing solid tumors. The Phase 1 trial includes a dose escalation portion currently enrolling patients with previously treated advanced or metastatic non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal squamous cell carcinoma, and colorectal cancer. The company expects to provide an initial safety update from the ALX2004 trial in the first half of 2026. No results have been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ALX Oncology Holdings Inc. published the original content us","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDLbnpwxc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B64PRP62.GBP","LU2095319765.USD","LU0314104364.USD","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","BK4588","SG9999014013.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","NDAQ","BK4585","SG9999014021.USD","ALXO"],"gpt_icon":0},{"id":"2589872063","title":"ALX Oncology Reports 92% Complete Response Rate with Evorpacept Combo in Frontline Indolent B-Cell Lymphoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2589872063","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589872063?lang=en_us&edition=fundamental","pubTime":"2025-12-07 21:00","pubTimestamp":1765112412,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings Inc. has announced positive results from an ongoing Phase 2 investigator-sponsored trial evaluating evorpacept  in combination with standard-of-care rituximab and lenalidomide for patients with untreated indolent B-cell non-Hodgkin lymphoma . The study reported a complete response rate of 92% with the combination therapy, comparing favorably to an approximate historical 50% complete response rate for rituximab and lenalidomide alone. The regimen was reported to be well-tolerated and demonstrated notable anti-tumor activity in the frontline treatment setting. These data are being presented at the American Society of Hematology  Annual Meeting 2025 in Orlando, Florida, during a poster session on December 7, 2025. Further evaluation of minimal residual disease eradication rates is planned as the trial follow-up continues.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251207:nNDL8GKNLv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","ALXO","IE00BGHQF748.EUR","NDAQ","BK4139","LU2095319765.USD","BK4585","BK4588","LU2210149790.SGD","BK4112","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2589034872","title":"ALX Oncology Announces Positive Results From Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination With Standard-of-Care Treatment in Patients With Indolent B-Cell Non-Hodgkin Lymphoma, at Ash Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589034872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589034872?lang=en_us&edition=fundamental","pubTime":"2025-12-07 21:00","pubTimestamp":1765112402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251207:nTUA4ZQGKK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALXO","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}]}}